Westlake Village BioPartners Closes Two VC Funds Totaling $500m

Sean Harper/Beth Seidenberg-Helmed Firm Also Launches Acelyrin

 
• By Mandy Jackson

A $70m fund will back prior investments, while a $430m fund will launch new biotech firms. Harper and Seidenberg tapped into their Amgen connections for the CEO who helms new company Acelyrin.

Los Angeles-based Westlake said the only piece missing in LA's biotech hub previously was a local VC presence • Source: Shutterstock

More from Financing

More from Business